What You Should Know:
- The U.S. Department of Health and Human Services (HHS) has announced a new regulatory reform that will give doctors and patients real-time access to prescription drug information.
- The rule, which takes effect on October 1, will allow millions of Americans for the first time to compare drug prices, view out-of-pocket costs, and access prior authorization requirements. The reform aims to help them identify the most cost-effective treatments and prevent
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis
What You Should Know:
- Philips has unveiled new findings from its Future Health Index 2025: Cardiology Snapshot, a report that explores how cardiac care professionals and patients view the role of AI and digital health technologies in transforming heart health.
- The report offers a candid look at the pressing challenges in cardiology and the growing potential of AI to alleviate them. Cardiovascular disease affects over 640 million people globally, putting an enormous strain
Read More
Nuclear Care Partners Launches Care+ Kidney Program for Atomic Workers with CKD
What You Should Know:
- Nuclear Care Partners, a leading provider of specialized in-home care for former Department of Energy (DOE) and nuclear weapons workers, has announced the launch of Care+ Kidney.
- The new program is designed specifically for former atomic workers who are living with chronic kidney disease (CKD). Care+ Kidney was developed by nurses with deep clinical expertise in occupational illness and delivers a personalized, outcomes-driven approach to managing CKD
Read More
A New Era in Prostate Care: The Shift from Overtreatment to Precision Diagnosis
Understanding Prostate Cancer: Not All Are the Same
Prostate cancer is the second most common cancer in men, but what many don’t realize is that it’s not a one-size-fits-all disease. There are different types of prostate cancer—some grow very slowly and may never cause harm, while others are aggressive and can spread quickly if not treated in time.
Non-aggressive (low-risk) prostate cancer often grows so slowly that it may never need treatment. Many men with this type can safely
Read More
The AI Paradox: Why AI Agents Are the Newest Risk in Healthcare Security
As artificial intelligence agents become increasingly embedded in clinical workflows - making decisions, accessing records, and interacting with patients - the traditional boundaries of identity and access management are blurring. In healthcare environments where clinical staff already represent a significant security risk due to complex workflows and high-pressure conditions, the introduction of AI agents acting on behalf of humans adds a new and underregulated attack surface.
These agents
Read More
Oatmeal Health and Coreline Soft Partner to Distribute AI-Powered Lung Cancer Screening in U.S.
What You Should Know:
- Oatmeal Health and Coreline Soft, a publicly traded leader in AI imaging from South Korea and the U.S., have partnered to co-develop and distribute AI-powered lung cancer screening solutions across the U.S.
- The strategic collaboration aims to accelerate equitable access to early detection and screening for the communities that need it most.
Expanding Lung Cancer Screening Access in FQHCs
According to the Lung Cancer Foundation of America, lung
Read More
Alphabet’s Verily Shuts Down Medical Device Division, Shifts Focus to AI
What You Should Know:
- Alphabet's Verily announced in an internal memo that is has closed its medical device division and laid off staff. The exact number of employees affected was not revealed.
- According to a spokesperson, the company has made the "difficult decision to discontinue manufacturing medical devices" and will no longer support them moving forward. This move is a continuation of a broader strategic shift from Alphabet in 2023, which saw the company cut 12,000 positions
Read More
Eyebot Raises $20M to Scale 90-Second Vision Test and Doctor-Verified Prescriptions
What You Should Know:
- Eyebot, the company behind the 90-second vision test kiosk that delivers doctor-verified glasses prescriptions, today announced it has raised $20 million in Series A funding. The round was led by General Catalyst, with participation from returning investors AlleyCorp, Baukunst, Village Global, and Ubiquity Ventures.
- Eyebot is redefining how people access vision care by eliminating traditional barriers like appointment delays, insurance hurdles, and
Read More
HeartFocus by DESKi Launches in U.S. on Butterfly Network Handheld Ultrasound
What You Should Know:
- HeartFocus, the revolutionary, AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, today announced its U.S. commercial launch.
- HeartFocus will initially be available on Butterfly Network’s handheld ultrasound devices, the FDA-cleared software enables any healthcare professional to conduct diagnostic-quality heart ultrasounds after just hours of training. Health systems, primary care clinics, and clinical education institutions can
Read More
Reach7 Diabetes Studios and Trileas Partner to Launch CARES Program for At-Risk Communities
What You Should Know:
- Reach7 Diabetes Studios has announced that Trileas is the first official sponsor and founding member of its CARES Program. The program is a third-party sponsored initiative that provides screenings for high-risk individuals and subsidized memberships for those most in need.
- The partnership with Trileas, a company dedicated to delivering affordable connectivity and healthcare solutions, will help the CARES Program reach further, expand access, and transform
Read More
